RD Saúde Overview

  • Year Founded
  • 1905

Year Founded

  • Status
  • Public

  • Employees
  • 75,594

Employees

  • Stock Symbol
  • RADL3

Stock Symbol

  • Investments
  • 18

  • Share Price
  • $2.53
  • (As of Friday Closing)

RD Saúde General Information

Description

Raia Drogasil SA operates a chain of pharmacies in Brazil. The company is mainly engaged in the retail sale of medicines, perfumery, personal care and beauty products, cosmetics, dermocosmetics, and specialty medicines. Its pharmacies mainly operate under the Drogasil and Raia brands.

Contact Information

Formerly Known As
Droga Raia, Pharmacia Raia
Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • Avenida Corifeu de Azevedo Marques 3097
  • Butantã
  • Sao Paulo, State of São Paulo 05339-900
  • Brazil
Primary Industry
Distributors (Healthcare)
Stock Exchange
BVMF
Corporate Office
  • Avenida Corifeu de Azevedo Marques 3097
  • Butantã
  • Sao Paulo, State of São Paulo 05339-900
  • Brazil

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

RD Saúde Stock Performance

As of 13-Nov-2026, RD Saúde’s stock price is $2.53. Its current market cap is $4.43B with 1.75B shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$2.53 $2.55 $2.49 - $5.27 $4.43B 1.75B 12.5M $0.15

RD Saúde Financials Summary

As of 30-Sep-2026, RD Saúde has a trailing 12-month revenue of $9.1B.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 7,695,249 8,868,928 7,245,378 11,781,257
Revenue 9,076,426 7,906,525 7,213,833 6,797,259
EBITDA 760,847 636,623 583,405 550,628
Net Income 248,489 231,719 222,672 211,072
Total Assets 4,922,237 4,593,823 3,585,846 4,140,446
Total Debt 1,696,658 1,612,291 1,248,761 1,456,248
Public Fundamental Data provided by Morningstar, Inc. disclaimer

RD Saúde Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore RD Saúde‘s full profile, request access.

Request a free trial

RD Saúde Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

RD Saúde Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore RD Saúde‘s full profile, request access.

Request a free trial

RD Saúde Investments & Acquisitions (18)

RD Saúde’s most recent deal was a Merger/Acquisition with Stix Fidelidade for . The deal was made on 21-May-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Stix Fidelidade 21-May-2026 Merger/Acquisition Business/Productivity Software
4BIO Medicamentos Especiais 03-May-2024 Secondary Transaction - Private Specialty Retail
SafePill 23-Nov-2023 Merger/Acquisition Other Healthcare Services
eLoopz 23-Aug-2022 Merger/Acquisition Business/Productivity Software
Full Nine Digital Consultoria 04-Jan-2022 Seed Round Media and Information Services (B2B)
You’re viewing 5 of 18 investments and acquisitions. Get the full list »

RD Saúde ESG

Risk Overview

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Food Retailers

Industry

Rank

Percentile

Drug Retail

Subindustry

Rank

Percentile

To view RD Saúde’s complete esg history, request access »

RD Saúde Exits (3)

RD Saúde’s most recent exit was on 03-May-2024 from 4BIO Medicamentos Especiais. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
4BIO Medicamentos Especiais 03-May-2024 Completed
4BIO Medicamentos Especiais 01-Jan-2020 Completed
4BIO Medicamentos Especiais 01-Jan-2015 Merger/Acquisition Completed
To view RD Saúde’s complete exits history, request access »

RD Saúde Affiliates

Subsidiaries (5)

Name Industry Location Year Founded
Manipulaê Sao Paulo, Brazil 2016
Amplimed Chapeco, Brazil 2015
DR. CUCO Sao Paulo, Brazil 2014
Raia (Distributors) Sao Paulo, Brazil
Stix Fidelidade Barueri, Brazil

RD Saúde FAQs

  • When was RD Saúde founded?

    RD Saúde was founded in 1905.

  • Where is RD Saúde headquartered?

    RD Saúde is headquartered in Sao Paulo, Brazil.

  • What is the size of RD Saúde?

    RD Saúde has 75,594 total employees.

  • What industry is RD Saúde in?

    RD Saúde’s primary industry is Distributors (Healthcare).

  • Is RD Saúde a private or public company?

    RD Saúde is a Public company.

  • What is RD Saúde’s stock symbol?

    The ticker symbol for RD Saúde is RADL3.

  • What is the current stock price of RD Saúde?

    As of 13-Nov-2026 the stock price of RD Saúde is $2.53.

  • What is the current market cap of RD Saúde?

    The current market capitalization of RD Saúde is $4.43B.

  • What is RD Saúde’s current revenue?

    The trailing twelve month revenue for RD Saúde is $9.1B.

  • What is RD Saúde’s annual earnings per share (EPS)?

    RD Saúde’s EPS for 12 months was $0.15.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process